---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000062"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-01-24T23:59:59+00:00"
generated_at: "2026-06-20T10:45:39.750017+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioSig raises $1.3M via PIPE: 1.67M shares at $0.7806 and warrants for 832,692 shares

## Summary
- Sold 1,665,384 shares at $0.7806/share and warrants to buy up to 832,692 shares at $0.7181.
- Warrants exercisable six months after issuance, expire five and a half years from issuance.
- Private placement exempt under Section 4(a)(2) and Regulation D; proceeds ~$1.3 million.
- No use of proceeds disclosed; offering closed on January 23, 2023.

## SEC filing metadata
- accession: 0001185185-23-000062
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-01-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000062/0001185185-23-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000062/biosig20230123_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000062
- JSON: https://secwatch.observer/filing/0001185185-23-000062.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000062.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Purchase Agreement with an accredited investor (the "Investor") valued at $1,299,998.75 (effective 2023-01-23).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: an accredited investor (the "Investor")
  - Value: $1,299,998.75
  - Effective: 2023-01-23
  source text: On January 23, 2023, BioSig Technologies, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Investor”), pursuant to which the Company sold to the Investor 1,665,384 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) at a purchase price of $0.7806 per share, and a warrant (the “Warrant”) to purchase up to 832,692 shares of Common Stock (the “Warrant Shares” and together with the Shares and Warrant, the “Securities”), at an exercise price of $0.7181 per share, that will become exercisable six months after the date of issuance and will expire five and one-half years following the date of issuance, in exchange for consideration of $1,299,998.75.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000062/0001185185-23-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.